Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Serum tetranectin and CA125 in endometrial adenocarcinoma.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  1. The Role of Local Therapy in Multi-focal Epithelioid Haemangioendothelioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association of CD31 and p53 With Survival of Ovarian Cancer Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The Influence of Cyst Emptying, Lymph Node Resection and Chemotherapy on Survival in Stage IA and IC1 Epithelial Ovarian Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A 24-h a la carte food service as support for patients at nutritional risk: a pilot study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  3. Progesterone receptor levels independently predict survival in endometrial adenocarcinoma.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Vis graf over relationer
BACKGROUND: CA125 and tetranectin (TN) are prognostic markers in ovarian cancer. This study examines the values of these markers in endometrial cancer. MATERIALS AND METHODS: TN and CA125 were determined preoperatively in 99 patients with primary endometrioid adenocarcinoma and evaluated in relation to tumor grade, stage and cancer survival. RESULTS: The CA125 levels correlated significantly with tumor stage. Dichotomized according to a cut-off level of 35 U/ml, CA125 significantly correlated with cancer death. Multivariate regression analysis of cancer survival time showed that CA125 > 35 U/ml was not an independent factor when stage was introduced. TN levels were within the normal range in all patients and did not show any association with tumor grade, stage or survival. CONCLUSIONS: The study confirmed the role of CA125 as a prognostic factor in endometrial cancer and may be of aid in pointing out patients at high risk, whereas tetranectin did not show any prognostic effect.
Bidragets oversatte titelSerum tetranectin and CA125 in endometrial adenocarcinoma.
OriginalsprogEngelsk
TidsskriftAnticancer Research
Vol/bind20
Udgave nummer5C
Sider (fra-til)3903-3906
Antal sider4
ISSN0250-7005
StatusUdgivet - 2000

ID: 32532807